Future perspectives/quo vadis psoriasis treatment? Immunology, pharmacogenomics, and epidemiology

被引：4
作者：
Kimball, Alexa B. [1 ]
Kupper, Thomas S. [1 ]
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02114 USA
来源：
CLINICS IN DERMATOLOGY | 2008年 / 26卷 / 05期
关键词：
D O I：
10.1016/j.clindermatol.2007.11.007
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Advances in the understanding and treatment of psoriasis in the past several years have been remarkable. New frontiers include better understanding the immunologic pathways that underlie the disease and the development of personalized strategies to maximize the benefit and minimize the risk for patients. Although a cure may not be imminent, there are sonic strategies under examination that may lead us closer to this goal. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码：554 / 561
页数：8
相关论文
共 71 条
  • [1] Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
    Aggarwal, S
    Ghilardi, N
    Xie, MH
    de Sauvage, FJ
    Gurney, AL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) : 1910 - 1914
  • [2] Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4-induced activation of human keratinocytes
    Albanesi, C
    Scarponi, CS
    Cavani, A
    Federici, M
    Nasorri, F
    Girolomoni, G
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (01) : 81 - 87
  • [3] Antoni C, 2005, J AM ACAD DERMATOL, V52, pP187
  • [4] Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity
    Arican, O
    Aral, M
    Sasmaz, S
    Ciragil, P
    [J]. MEDIATORS OF INFLAMMATION, 2005, (05) : 273 - 279
  • [5] Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent
    Berends, M. A. M.
    Snoek, J.
    De Jong, E. M. G. J.
    De Kerkhof, P. C. M. Van
    Van Oijen, M. G. H.
    Van Krieken, J. H.
    Drenth, J. P. H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (05) : 805 - 811
  • [6] TH-17 cells in the circle of immunity and autoimmunity
    Bettelli, Estelle
    Oukka, Mohamed
    Kuchroo, Vijay K.
    [J]. NATURE IMMUNOLOGY, 2007, 8 (04) : 345 - 350
  • [7] Boniface K, 2005, EUR CYTOKINE NETW, V16, P309
  • [8] A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes
    Cargill, Michele
    Schrodi, Steven J.
    Chang, Monica
    Garcia, Veronica E.
    Brandon, Rhonda
    Callis, Kristina P.
    Matsunami, Nori
    Ardlie, Kristin G.
    Civello, Daniel
    Catanese, Joseph J.
    Leong, Diane U.
    Panko, Jackie M.
    McAllister, Linda B.
    Hansen, Christopher B.
    Papenfuss, Jason
    Prescott, Stephen M.
    White, Thomas J.
    Leppert, Mark F.
    Krueger, Gerald G.
    Begovich, Ann B.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 80 (02) : 273 - 290
  • [9] IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis
    Chan, Jason R.
    Blumenschein, Wendy
    Murphy, Erin
    Diveu, Caroline
    Wiekowski, Maria
    Abbondanzo, Susan
    Lucian, Linda
    Geissler, Richard
    Brodie, Scott
    Kimball, Alexa B.
    Gorman, Daniel M.
    Smith, Kathleen
    Malefyt, Rene de Waal
    Kastelein, Robert A.
    McClanahan, Terrill K.
    Bowman, Edward P.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (12) : 2577 - 2587
  • [10] A marker for Stevens-Johnson syndrome
    Chung, WH
    Hung, SI
    Hong, HS
    Hsih, MS
    Yang, LC
    Ho, HC
    Wu, JY
    Chen, YT
    [J]. NATURE, 2004, 428 (6982) : 486 - 486
12345678